Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

81.50
-1.4400-1.74%
Post-market: 81.500.00000.00%19:30 EDT
Volume:1.74M
Turnover:143.16M
Market Cap:15.96B
PE:-22.84
High:83.37
Open:82.89
Low:81.36
Close:82.94
52wk High:93.42
52wk Low:46.81
Shares:195.81M
Float Shares:154.00M
Volume Ratio:0.63
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-6.34
PE(LYR):-21.53

Loading ...

BridgeBio files to sell 24.63M shares of common stock for holders

TIPRANKS
·
Jul 25

Bridgebio Pharma Inc: Files for Offering of up to 24.6 Mln Common Shares by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Jul 25

Is FDA’s Encaleret NDA Acceptance Redefining the Investment Case For BridgeBio Pharma (BBIO)?

Simply Wall St.
·
Jul 24

BridgeBio announces FDA acceptance of encaleret NDA

TIPRANKS
·
Jul 22

Bridgebio Says FDA Accepts Encaleret NDA for ADH1, Sets May 8, 2027 PDUFA Date

Reuters
·
Jul 22

Bridgebio Pharma - to Initiate Reclaim-hp Phase 3 Study of Encaleret in Chronic Hypoparathyroidism

THOMSON REUTERS
·
Jul 22

Bridgebio Pharma - FDA not Planning Advisory Committee Meeting for Encaleret Nda

THOMSON REUTERS
·
Jul 22

Bridgebio Announces FDA Acceptance of Nda for Encaleret for Adh1

THOMSON REUTERS
·
Jul 22

Bridgebio Pharma - Phase 3 Calibrate Trial of Encaleret in Adh1 Achieves All Primary and Key Secondary Endpoints

THOMSON REUTERS
·
Jul 22

Bridgebio Pharma - FDA Sets Pdufa Target Action Date of May 8, 2027 for Encaleret Nda

THOMSON REUTERS
·
Jul 22

U.S. Research Roundup- Anterix, Fidus Investment, Nextpower

Reuters
·
Jul 20

Bridgebio Pharma Inc : Jefferies Raises Target Price to $110 from $100

THOMSON REUTERS
·
Jul 20

Yext, Mission Produce, and 3 More Stocks See Action from Activist Investors

Dow Jones
·
Jul 18

Bridgebio Pharma is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 17

Bridgebio Pharma Inc : Citigroup Raises Target Price to $93 from $82

THOMSON REUTERS
·
Jul 16

Bridgebio Pharma Director Jennifer E. Cook Reports Disposal of Common Shares Worth $13.1 Million

Reuters
·
Jul 14

Bridgebio Pharma is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 13

Bridgebio Grants 83,283 Restricted Stock Units to 37 New Employees Under Inducement Plan

Reuters
·
Jul 11

Bridgebio Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 11

Movement Alert|BridgeBio Pharma Falls 5.02% in Regular Trading, Broad Biotech Sector Selloff Triggers Profit-Taking After Recent Rally

Market Focus
·
Jul 11